Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Effect on Ambulatory Blood Pressure in Type 2 Diabetes
NCT02299388Phase 4Completed
- Sponsor
- Tulane University
- Start
- Oct 2014
- Primary completion
- Nov 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Liraglutide with Placebo (2 arms). Primary endpoint: Change in Systolic Blood Pressure as Measured by Ambulatory Blood Pressure Monitors at 8 weeks. Started Oct 2014; status: completed.
02
Drugs
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02299388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299388.